ACS | acute chest syndrome |
BMI | body mass index |
DOVE | Determining Effects of Platelet Inhibition on Vaso-Occlusive Events |
HbSβ0 | haemoglobin Sβ (0) thalassemia |
HbSS | homozygous hemoglobin S |
HU | hydroxyurea |
IV | intravenous |
SAEs | serious adverse events |
SCA | sickle cell anemia |
SSA | Sub-Saharan Africa |
VOCs | vaso-occlusive crisis |